MusclePharm Corporation (OTC BB:MSLP.OB) is one of the fastest growing nutritional supplement companies in the United States. MSLP announced today that a distribution agreement with Sportika Export Inc. Sportika is a leading sports nutrition distributor to over 130 countries internationally.
MusclePharm’s multiple products are currently available in 1,200 of the top GNC stores in the United States, as well as over 450 Vitamin Shoppe stores. MSLP’s award-winning products - Assault, Battle Fuel, Bullet Proof, Combat Powder, Recon & Shred Matrix -are also available online at gnc.com, bodybuilding.com, amazon.com & many other locations.
“We are very excited about the opportunity to expand distribution into over 130 markets as we continue to grow MusclePharm’s international brand presence,” said Brad Pyatt, MusclePharm’s Chief Executive Officer. “Creating a strategic partnership with Sportika Export will allow us to broaden our nutritional product formulations availability in the global healthy-living & wellness industry as we strive to increase sales & profitability long-term.”
MusclePharm will begin to distribute products with Sportika Export in September of 2010.
MusclePharm is headquartered in Aurora, Colorado and is a fast-growing developer & manufacturer of safe, scientifically approved, nutritional supplements that are free of banned substances & tested by athletes.
Herbalife Ltd. (NYSE:HLF) recently reported a record second quarter, raises FY’10 guidance & increases quarterly dividend. Worldwide volume growth of 19.9% including U.S. volume growth of 21.8% compared to the prior year period. Second quarter EPS increased 71.4% to $1.32 compared to the prior year period. Raises FY’10 EPS guidance to a range of $4.30 to $4.40 on higher volume and net sales growth. Repurchased 1.1 million shares during the quarter under the existing $1 billion authorization. Board of Directors authorizes increase in quarterly cash dividend from $0.20 to $0.25.
Herbalife Ltd., a network marketing company, sells weight management, nutritional supplement, energy, sports & fitness and personal care products worldwide.
Perrigo Company (NASDAQ:PRGO) reported recently that they have filed with the FDA & ANDA for butoconazole nitrate vaginal cream, 2% and that it has notified KV Pharmaceutical Company, the owner of the NDA as well as FemmePharma, the listed owner of the patent, of its ANDA filing. KV is a licensee under the patent. PRGO believes it is first to file on this product.
Perrigo Company, through its subsidiaries, develops, manufactures, & distributes over-the-counter (OTC) & prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (NYSEMKT:API) & medical diagnostic products worldwide. PRGO is the world’s largest manufacturer of OTC pharmaceutical products for the store brand market.
Sign Up for our Free Stock Newsletter at http://www.pennyotcstock.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Our disclaimer (http://pennyotcstock.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations.
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. Crown Equity Holdings, Inc. (OTCPK:CRWE) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (OTCQB:MSLP).